EX-10.8 13 d411577dex108.htm CLINICAL AND COMMERCIAL MANUFACTURING AND SUPPLY AGREEMENT Portions Subject to Confidential Treatment Request Under Rule 24b-2 CLINICAL AND COMMERCIAL MANUFACTURING AND SUPPLY AGREEMENTClinical and Commercial Manufacturing and Supply Agreement • May 5th, 2020
THIS CLINICAL AND COMMERCIAL MANUFACTURING AND SUPPLY AGREEMENT (this “Agreement”) is made effective as of the 22nd day of December, 2010 (“Effective Date”) by and between BAXTER ONCOLOGY GmbH, with an address at Kantstrasse 2, 33790 Halle / Westphalia, Germany (“Baxter”) and CELATOR PHARMACEUTICALS, INC., a Delaware corporation, having offices at 303B College Road East, Princeton, New Jersey 08540 (“Celator”).
CLINICAL AND COMMERCIAL MANUFACTURING AND SUPPLY AGREEMENTClinical and Commercial Manufacturing and Supply Agreement • February 27th, 2018 • Jazz Pharmaceuticals PLC • Pharmaceutical preparations
THIS CLINICAL AND COMMERCIAL MANUFACTURING AND SUPPLY AGREEMENT (this “Agreement”) is made effective as of the 22nd day of December, 2010 (“Effective Date”) by and between BAXTER ONCOLOGY GmbH, with an address at Kantstrasse 2, 33790 Halle / Westphalia, Germany (“Baxter”) and CELATOR PHARMACEUTICALS, INC., a Delaware corporation, having offices at 303B College Road East, Princeton, New Jersey 08540 (“Celator”).
AMENDMENT NO. 1 CLINICAL AND COMMERCIAL MANUFACTURING AND SUPPLY AGREEMENTClinical and Commercial Manufacturing and Supply Agreement • May 8th, 2018 • Jazz Pharmaceuticals PLC • Pharmaceutical preparations
This Amendment No. 1 (“Amendment No. 1”) is entered into by JAZZ PHARMACEUTICALS IRELAND LIMITED (“JAZZ”) and BAXTER ONCOLOGY GmbH (“Baxter”) as of January 18, 2018 (“Amend No. 1 Effective Date”).
